Vivoryon Therapeutics AG had a revenue of 0.00 in the quarter ending Jun 30, 2024, with 100.00%. This bring the company's revenue in the last twelve months to -3.62M, Decreased 0.00%. In the fiscal year ending Dec 31, 2023, Vivoryon Therapeutics AG had annual revenue of -3.62M with -Infinity% growth.